Cancer diagnostics News and Research

RSS

New imaging tool to track cellular events that may initiate obesity-related conditions

A collaborative team of researchers at Utah State University and the University of Central Florida developed a tool to track cellular events that may lead to obesity-related conditions in people.

25 Feb 2020

UCI neuro-oncologist uses comprehensive approach to battle brain cancer

When you're facing a cancer diagnosis with an average survival span of 12 to 18 months, every milestone is a victory.

23 Feb 2020

Simple blood test measures the body's immune response to improve ovarian cancer diagnosis

Researchers have developed a simple blood test that measures the body's own immune response to improve diagnosis of ovarian cancer.

17 Feb 2020

A high number of lifetime sexual partners raises cancer risk

A new study seems to reinforce traditional common sense and good morals: people who play around with sex tend to have a higher risk of cancer. The study published online in the journal BMJ Sexual and Reproductive Health in February 2020 shows that having ten or more sex partners increases the risk of cancer in both men and women. And in women, this pattern of sexual behavior increases the chances of a chronic debilitating illness.

13 Feb 2020

NPF names Rush as National Center of Excellence for Pancreatic Cancer

The National Pancreas Foundation has named Rush University Medical Center as a National Center of Excellence for Pancreatic Cancer, a designation given to hospitals that have demonstrated the multi-disciplinary approach, social support and advanced research resources needed to successfully treat this devastating disease.

13 Feb 2020

Hybrid microscope could bring cancer diagnosis into the digital era

By adding infrared capability to the ubiquitous, standard optical microscope, researchers at the University of Illinois at Urbana-Champaign hope to bring cancer diagnosis into the digital era.

12 Feb 2020

Sexual orientation affects skin cancer risk in the USA

A new study published in the journal JAMA Dermatology in February 2020 shows a higher rate of indoor tanning and a corresponding increase in skin cancer, among men with homosexual or bisexual preferences compared to heterosexual men.

12 Feb 2020

Study uncovers new avenue for melanoma diagnosis and therapies

A new way to spot melanoma cells circulating in the blood has the potential to significantly improve the monitoring of cancer patients and guide future treatment.

10 Feb 2020

Routine screenings prevent most cervical cancers

Cervical cancer is the third most common cancer in women worldwide, but most American women can prevent it by being screened with tests that detect human papillomaviruses (HPV).

9 Feb 2020

Study: Smartphone apps for skin cancer diagnosis are poorly regulated and unreliable

Smartphone apps used as ‘early warning systems’ for skin cancer are poorly regulated and frequently cannot be relied upon to produce accurate results, according to new analysis by experts at the University of Birmingham.

7 Feb 2020

Largest genome study sheds light on how genetic glitches trigger tumor formation

It is well-known that when a gene mutates, it triggers tumor formation by stimulating abnormal cell growth and proliferation. Cancer starts from a mutant gene that kickstarts a series of abnormal growth, forming a tumor. However, the exact mechanism of how this happens remains unclear.

6 Feb 2020

Researchers discover new mutational phenomenon chromothripsis in cancer

Researchers at Harvard Medical School and EMBL-EBI have carried out the largest analysis across cancer types of the newly discovered mutational phenomenon chromothripsis.

6 Feb 2020

Magnetically levitated plasma proteins could vastly improve diagnosis of diseases

Researchers at Michigan State University's Precision Health Program have helped develop a fascinating new method for detecting the density of proteins in the blood - a method that could vastly improve the rate at which diseases are detected and diagnosed.

5 Feb 2020

Expanded Medication Assistance Program increases access to vital cancer therapies

The Medical Assistance Program at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has helped more than 30,000 patients gain access to vital medications valued at more than $500 million, and a new program expansion will further increase access to vital cancer therapies for patients with the greatest financial need.

4 Feb 2020

RNA affecting skin cancer progression discovered

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin.

4 Feb 2020

Developing tests for genetic signs could lead to earlier cancer detection

Early signs of cancer can appear years before diagnosis and developing tests for these genetic signs could provide new ways to spot cancer early, according to new research led by the Crick and EMBL-EBI, and supported by an international cancer genomics consortium, the Pan-Cancer Analysis of Whole Genomes Project.

4 Feb 2020

$18 million gift will support UCLA's expansion of integrative psychosocial cancer care

An $18 million commitment from the Simms/Mann Family Foundation, led by Dr. Victoria Mann Simms and Ronald Simms, will support UCLA's expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.

30 Jan 2020

Annual lung cancer screening with LDCT reduces lung cancer deaths

The Dutch-Belgian Randomized Lung Cancer Screening Trial, known as the NELSON trial (de Koning et. al), published Jan. 29 in the New England Journal of Medicine (NEJM), reconfirms that annual lung cancer screening with low-dose computed tomography (LDCT) in high-risk patients significantly reduces lung cancer deaths.

30 Jan 2020

SU2C announces international team for fighting gastric cancer

Stand Up To Cancer announced today that an international team of experts will take a new approach to fighting the world's third-leading cause of cancer death -- stomach (or gastric) cancer.

28 Jan 2020

Psychedelic drug has enduring antianxiety and antidepressant effects in cancer patients

Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy appears to be associated with significant improvements in emotional and existential distress in cancer patients.

28 Jan 2020

Cancer diagnostics News and Research

New imaging tool to track cellular events that may initiate obesity-related conditions

UCI neuro-oncologist uses comprehensive approach to battle brain cancer

Simple blood test measures the body's immune response to improve ovarian cancer diagnosis

A high number of lifetime sexual partners raises cancer risk

NPF names Rush as National Center of Excellence for Pancreatic Cancer

Hybrid microscope could bring cancer diagnosis into the digital era

Sexual orientation affects skin cancer risk in the USA

Study uncovers new avenue for melanoma diagnosis and therapies

Routine screenings prevent most cervical cancers

Study: Smartphone apps for skin cancer diagnosis are poorly regulated and unreliable

Largest genome study sheds light on how genetic glitches trigger tumor formation

Researchers discover new mutational phenomenon chromothripsis in cancer

Magnetically levitated plasma proteins could vastly improve diagnosis of diseases

Expanded Medication Assistance Program increases access to vital cancer therapies

RNA affecting skin cancer progression discovered

Developing tests for genetic signs could lead to earlier cancer detection

$18 million gift will support UCLA's expansion of integrative psychosocial cancer care

Annual lung cancer screening with LDCT reduces lung cancer deaths

SU2C announces international team for fighting gastric cancer

Psychedelic drug has enduring antianxiety and antidepressant effects in cancer patients

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News